Pemetrexed Dipotassium Injection, Powder, Lyophilized, For Solution
Product Images NDC 83831-112

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pemetrexed Dipotassium (NDC 83831-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Be85c73b 4817 4f30 A1fc F3014993d209 153 2)

FDA Label Image

Image (Be85c73b 4817 4f30 A1fc F3014993d209 175 2)

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 01)

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 02)

This is a comparative data table showing patient survival time (in months) for two different treatment regimens (PC and GC). The number of patients at risk over time is shown for each treatment group. PC had 82 patients at the start and GC had 83 patients at the start. This information can be used to analyze and compare the effectiveness of the two treatments on patient survival.*

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 03)

This is a data table showing the survival probability over time for two groups, labeled PC and GC. The groups are being compared based on their survival time in months. The table also includes the number of patients at risk at various time intervals in both groups. The data can be utilized for survival analysis or medical research purposes.*

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 04)

This text is showing a survival time chart for patients at risk, with a breakdown by months. The chart includes information on the number of patients at risk over the months.*

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 05)

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 06)

This description presents survival time data in months for patients who received Pomoeed (325 patients) and Placebo (156 patients). It shows the number of patients at risk at various time intervals. The data indicates the survival outcomes over time for the treatment group compared to the control group.*

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 07)

This text appears to be a survival probability data set showing the survival time in months for patients receiving Pemovoxed and Placebo treatments. The table includes the number of patients at risk at different time points.*

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 08)

FDA Label Image

Image (E6c9e0de 4141 4daf 9bab 31d6c394a168 09)

FDA Label Image

Pemetrexed For Injection, 100mg/vial- Container Label (E6c9e0de 4141 4daf 9bab 31d6c394a168 10)

FDA Label Image

Pemetrexed For Injection, 100mg/vial- Carton Label (E6c9e0de 4141 4daf 9bab 31d6c394a168 11)

This is a pharmaceutical label containing batch details, 2D barcode, expiration date, lot number, and dosage instructions for Pemetrexed for Injection. The medication comes in vials containing 100 mg and should be stored at controlled room temperature. The label also provides instructions for reconstitution and administration of the drug. Additionally, it includes manufacturer information and a warning about the hazardous nature of the drug.*

FDA Label Image

Pemetrexed For Injection, 500mg/vial- Container Label (E6c9e0de 4141 4daf 9bab 31d6c394a168 12)

FDA Label Image

Pemetrexed For Injection, 500mg/vial- Carton Label (E6c9e0de 4141 4daf 9bab 31d6c394a168 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.